Protagonist Therapeutics, Inc

CHARLES SCHWAB INVESTMENT MANAGEMENT INC PTGX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

556,762

Value ($000)

48,628

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	48,628	0.0%	556,762	12/31/2025
2025 Q3	11/10/2025	36,728	0.0%	552,877	9/30/2025
2025 Q2	8/12/2025	31,800	0.0%	575,364	6/30/2025
2025 Q1	9/15/2025	26,971	0.0%	557,718	3/31/2025
2024 Q4	2/6/2025	22,327	0.0%	578,409	12/31/2024
2024 Q3	11/12/2024	25,448	0.0%	565,503	9/30/2024
2024 Q2	8/12/2024	18,214	0.0%	525,653	6/30/2024
2024 Q1	5/9/2024	14,366	0.0%	496,562	3/31/2024
2023 Q4	2/6/2024	10,441	0.0%	455,321	12/31/2023
2023 Q3	11/8/2023	7,324	0.0%	439,102	9/30/2023
2023 Q2	8/10/2023	11,590	0.0%	419,610	6/30/2023
2023 Q1	5/12/2023	8,307	0.0%	361,158	3/31/2023
2022 Q4	2/13/2023	3,710	0.0%	340,021	12/31/2022
2022 Q3	11/14/2022	2,813	0.0%	333,643	9/30/2022
2022 Q2	8/15/2022	2,569	0.0%	324,758	6/30/2022
2022 Q1	5/13/2022	7,703	0.0%	325,259	3/31/2022
2021 Q4	2/11/2022	10,848	0.0%	317,179	12/31/2021
2021 Q3	11/16/2021	5,491	0.0%	309,832	9/30/2021
2021 Q2	8/16/2021	12,629	0.0%	281,378	6/30/2021
2021 Q1	5/17/2021	6,776	0.0%	261,587	3/31/2021
2020 Q4	2/16/2021	4,541	0.0%	225,220	12/31/2020
2020 Q3	11/13/2020	4,233	0.0%	216,486	9/30/2020
2020 Q2	8/20/2020	1,008	0.0%	57,072	6/30/2020
2020 Q1	5/15/2020	310	0.0%	43,904	3/31/2020
2019 Q4	2/7/2020	309	0.0%	43,753	12/31/2019